世界の仮想診断市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP02392)
◆英語タイトル:Global Virtual Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP02392
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:124
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、仮想診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。仮想診断の種類別市場規模(消化器仮想診断、眼科仮想診断、循環器仮想診断、その他)、用途別市場規模(病院、クリニック、家庭、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Medtronic、HearX IP、Cardiologs Technologies、Olympus Corporation、Healthy.io Ltd.、AliveCor Inc.、IDx Technologies Inc.、Eyenuk, Inc.、CapsoVision, Inc.、Hill-Rom Holdings, Inc.、SkinVision、Monitored Therapeutics Inc.、Sight Diagnostics、Phelcom Technologies、ResApp Health Limited
・地域別グローバル市場分析 2015年-2020年
・仮想診断の北米市場(アメリカ、カナダ、メキシコ)
・仮想診断のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・仮想診断のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・仮想診断の南米市場(ブラジル、アルゼンチン)
・仮想診断の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:消化器仮想診断、眼科仮想診断、循環器仮想診断、その他
・用途別分析:病院、クリニック、家庭、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Virtual Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Virtual Diagnostic sales will be xx in 2020 from Virtual Diagnostic million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Virtual Diagnostic market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Virtual Diagnostic industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Virtual Diagnostic and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Virtual Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Virtual Diagnostic market has been segmented into:
Gastrointestinal Virtual Diagnostics
Ophthalmology Virtual Diagnostics
Cardiology Virtual Diagnostics
Other

By Application, Virtual Diagnostic has been segmented into:
Hospital
Clinic
Household
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Virtual Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Virtual Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Virtual Diagnostic market.

The report offers in-depth assessment of the growth and other aspects of the Virtual Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Virtual Diagnostic Market Share Analysis
Virtual Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Virtual Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Virtual Diagnostic sales, revenue and market share for each player covered in this report.

The major players covered in Virtual Diagnostic are:
Medtronic
HearX IP
Cardiologs Technologies
Olympus Corporation
Healthy.io Ltd.
AliveCor Inc.
IDx Technologies Inc.
Eyenuk, Inc.
CapsoVision, Inc.
Hill-Rom Holdings, Inc.
SkinVision
Monitored Therapeutics Inc.
Sight Diagnostics
Phelcom Technologies
ResApp Health Limited
Among other players domestic and global, Virtual Diagnostic market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Virtual Diagnostic Market Overview
1.1 Product Overview and Scope of Virtual Diagnostic
1.2 Classification of Virtual Diagnostic by Type
1.2.1 Global Virtual Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Virtual Diagnostic Revenue Market Share by Type in 2019
1.2.3 Gastrointestinal Virtual Diagnostics
1.2.4 Ophthalmology Virtual Diagnostics
1.2.5 Cardiology Virtual Diagnostics
1.2.6 Other
1.3 Global Virtual Diagnostic Market by Application
1.3.1 Overview: Global Virtual Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Other
1.4 Global Virtual Diagnostic Market by Regions
1.4.1 Global Virtual Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Virtual Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Virtual Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Virtual Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Virtual Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Virtual Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Virtual Diagnostic Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Virtual Diagnostic Industry Impact
1.5.1 COVID-19 Potential Implications for the Virtual Diagnostic
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Virtual Diagnostic
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 HearX IP
2.2.1 HearX IP Details
2.2.2 HearX IP Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 HearX IP SWOT Analysis
2.2.4 HearX IP Product and Services
2.2.5 HearX IP Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cardiologs Technologies
2.3.1 Cardiologs Technologies Details
2.3.2 Cardiologs Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cardiologs Technologies SWOT Analysis
2.3.4 Cardiologs Technologies Product and Services
2.3.5 Cardiologs Technologies Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Olympus Corporation
2.4.1 Olympus Corporation Details
2.4.2 Olympus Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Olympus Corporation SWOT Analysis
2.4.4 Olympus Corporation Product and Services
2.4.5 Olympus Corporation Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Healthy.io Ltd.
2.5.1 Healthy.io Ltd. Details
2.5.2 Healthy.io Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Healthy.io Ltd. SWOT Analysis
2.5.4 Healthy.io Ltd. Product and Services
2.5.5 Healthy.io Ltd. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 AliveCor Inc.
2.6.1 AliveCor Inc. Details
2.6.2 AliveCor Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AliveCor Inc. SWOT Analysis
2.6.4 AliveCor Inc. Product and Services
2.6.5 AliveCor Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 IDx Technologies Inc.
2.7.1 IDx Technologies Inc. Details
2.7.2 IDx Technologies Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 IDx Technologies Inc. SWOT Analysis
2.7.4 IDx Technologies Inc. Product and Services
2.7.5 IDx Technologies Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eyenuk, Inc.
2.8.1 Eyenuk, Inc. Details
2.8.2 Eyenuk, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eyenuk, Inc. SWOT Analysis
2.8.4 Eyenuk, Inc. Product and Services
2.8.5 Eyenuk, Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 CapsoVision, Inc.
2.9.1 CapsoVision, Inc. Details
2.9.2 CapsoVision, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CapsoVision, Inc. SWOT Analysis
2.9.4 CapsoVision, Inc. Product and Services
2.9.5 CapsoVision, Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hill-Rom Holdings, Inc.
2.10.1 Hill-Rom Holdings, Inc. Details
2.10.2 Hill-Rom Holdings, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hill-Rom Holdings, Inc. SWOT Analysis
2.10.4 Hill-Rom Holdings, Inc. Product and Services
2.10.5 Hill-Rom Holdings, Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.11 SkinVision
2.11.1 SkinVision Details
2.11.2 SkinVision Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 SkinVision SWOT Analysis
2.11.4 SkinVision Product and Services
2.11.5 SkinVision Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.12 Monitored Therapeutics Inc.
2.12.1 Monitored Therapeutics Inc. Details
2.12.2 Monitored Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Monitored Therapeutics Inc. SWOT Analysis
2.12.4 Monitored Therapeutics Inc. Product and Services
2.12.5 Monitored Therapeutics Inc. Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sight Diagnostics
2.13.1 Sight Diagnostics Details
2.13.2 Sight Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sight Diagnostics SWOT Analysis
2.13.4 Sight Diagnostics Product and Services
2.13.5 Sight Diagnostics Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.14 Phelcom Technologies
2.14.1 Phelcom Technologies Details
2.14.2 Phelcom Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Phelcom Technologies SWOT Analysis
2.14.4 Phelcom Technologies Product and Services
2.14.5 Phelcom Technologies Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.15 ResApp Health Limited
2.15.1 ResApp Health Limited Details
2.15.2 ResApp Health Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 ResApp Health Limited SWOT Analysis
2.15.4 ResApp Health Limited Product and Services
2.15.5 ResApp Health Limited Virtual Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Virtual Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Virtual Diagnostic Players Market Share
3.2.2 Top 10 Virtual Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Virtual Diagnostic Revenue and Market Share by Regions
4.2 North America Virtual Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Virtual Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Virtual Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Virtual Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Virtual Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Virtual Diagnostic Revenue by Countries
5.1 North America Virtual Diagnostic Revenue by Countries (2015-2020)
5.2 USA Virtual Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Virtual Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Virtual Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Virtual Diagnostic Revenue by Countries
6.1 Europe Virtual Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Virtual Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Virtual Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Virtual Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Virtual Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Virtual Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Virtual Diagnostic Revenue by Countries
7.1 Asia-Pacific Virtual Diagnostic Revenue by Countries (2015-2020)
7.2 China Virtual Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Virtual Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Virtual Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Virtual Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Virtual Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Virtual Diagnostic Revenue by Countries
8.1 South America Virtual Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Virtual Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Virtual Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Virtual Diagnostic by Countries
9.1 Middle East & Africa Virtual Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Virtual Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Virtual Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Virtual Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Virtual Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Virtual Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Virtual Diagnostic Market Forecast by Type (2019-2024)
10.3 Gastrointestinal Virtual Diagnostics Revenue Growth Rate (2015-2025)
10.4 Ophthalmology Virtual Diagnostics Revenue Growth Rate (2015-2025)
10.5 Cardiology Virtual Diagnostics Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Virtual Diagnostic Market Segment by Application
11.1 Global Virtual Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Virtual Diagnostic Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Household Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Virtual Diagnostic Market Size Forecast (2021-2025)
12.1 Global Virtual Diagnostic Market Size Forecast (2021-2025)
12.2 Global Virtual Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Virtual Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Virtual Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Virtual Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Virtual Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Virtual Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Medtronic、HearX IP、Cardiologs Technologies、Olympus Corporation、Healthy.io Ltd.、AliveCor Inc.、IDx Technologies Inc.、Eyenuk, Inc.、CapsoVision, Inc.、Hill-Rom Holdings, Inc.、SkinVision、Monitored Therapeutics Inc.、Sight Diagnostics、Phelcom Technologies、ResApp Health Limited

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の仮想診断市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Virtual Diagnostic Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。